openPR Logo
Press release

Dermatology Drugs Market Expansion with Biologics and Advanced Topical Therapies

04-07-2025 01:08 PM CET | Health & Medicine

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Dermatology Drugs Market

Dermatology Drugs Market

► Dermatology Drugs Market Poised for Significant Growth Amidst Rising Demand and Strategic Industry Consolidations

The global dermatology drugs market is on a trajectory of substantial expansion, driven by the increasing prevalence of skin disorders and a surge in innovative product launches. According to Maximize Market Research, the market is projected to grow at a compound annual growth rate (CAGR) of 12.9%, reaching nearly USD 139.91 billion by 2030. ​

Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/107428/

► Competitive Landscape

The dermatology drugs sector is characterized by the presence of key industry players such as Pfizer Inc., Merck & Co. Inc., Johnson & Johnson, AbbVie Inc., Amgen Inc., Galderma S.A., Eli Lilly and Company, Mylan N.V., GlaxoSmithKline plc, Sanofi, and LEO Pharma A/S. These companies are actively engaging in strategic initiatives, including mergers and acquisitions, to enhance their market positions and expand their product portfolios.

► Regional Insights and Strategic Developments

• United States: Growth and Consolidation

The United States remains a pivotal market for dermatology drugs, with significant mergers and acquisitions shaping the industry landscape. In May 2024, Johnson & Johnson acquired the rights to an experimental eczema treatment, NM26, from Numab Therapeutics for approximately $1.25 billion, marking its second eczema-related acquisition that month. Additionally, in July 2024, Hikma Pharmaceuticals agreed to acquire a portfolio of products from Xellia Pharmaceuticals for up to $185 million, aiming to bolster its injectable products division. ​

Eager to discover what's within? Secure your sample copy of the report today:https://www.maximizemarketresearch.com/request-sample/107428/

• Asia Pacific: Opportunities and Updation

The Asia Pacific region is witnessing robust growth in the dermatology drugs market, driven by increasing awareness and demand for aesthetic treatments. In September 2024, European private-equity firm ArchiMed made its first Asia deal by acquiring Jeisys Medical, a Korean producer of energy-based devices for medical aesthetic treatments, for $742 million. This strategic move underscores the region's growing significance in the global dermatology landscape. ​

• Europe: Trends and Expansion

Europe's dermatology market is experiencing notable trends, particularly in the anti-aging segment. In August 2024, L'Oréal acquired a 10% stake in dermatology firm Galderma, signaling its return to the anti-wrinkle injectables market after a decade-long focus on traditional cosmetics. This investment reflects the company's intent to explore the growing aesthetics market and aligns with trends in medicalization and premiumization within the beauty industry.

• Middle East and Africa: Emerging Opportunities

The Middle East and Africa region is emerging as a potential market for dermatology drugs, with increasing investments and collaborations aimed at addressing the rising prevalence of skin disorders. While specific mergers and acquisitions in this region are less prominent, the overall market dynamics indicate a growing interest from global pharmaceutical companies seeking to expand their footprint in these markets.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:https://www.maximizemarketresearch.com/request-sample/107428/

► Market Segmentation: In-Depth Analysis:

• by Disease

Psoriasis
Acne Vulgaris
Atopic Dermatitis
Eczema
Rosacea.
Itchthyosis.
Vitiligo
Others

Among them, psoriasis accounted for the largest portion of the medicine market, followed by atopic dermatitis, vitiligo, ichthyoses, rosacea, eczema, and acne. The persistent skin condition known as psoriasis, which has no known cure, is characterized by red, itchy patches that are typically found on the knees, elbows, trunk, and scalp. Although it cannot be spread from person to person, it can impact family members because of shared usage. The dermatology market has grown over time as a result.

• by Route Of Administration

Oral
Parenteral
Topical

The parenteral category has dominated the market based on the route of administration. The US Food and Drug Administration defines it as the process of administering a medication to a patient's body by injection, infusion, implantation, or another method. It is employed when a patient's need for a medication is urgent or when some medications are less effective when taken orally. Due to the easy access to a wide range of medications with dermatological provenance, the topical delivery market has also experienced growth. It is used to treat conditions affecting the surface or local area of the skin.

• by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Hospital pharmacies have held the largest share of the market, according to the distribution route. because patients prefer to receive care in hospitals. Certain medications that are not readily available are made readily available by hospital pharmacies. In contrast, the retail pharmacy category is expanding as a result of the market's growing need for affordable over-the-counter medications and is expected to increase its market share throughout the course of the projection year.

For deeper market insights, peruse the summary of the research report:https://www.maximizemarketresearch.com/market-report/global-dermatology-drugs-market/107428/

► Learn about the top players driving innovation in the Market :

1. Novartis AG
2. Bausch Health Companies Inc.,
3. Bristol-Myers Squibb Company,
4. Pfizer Inc.
5. Merck & Co. Inc.
6. Johnson & Johnson
7. AbbVie Inc.
8. Amgen Inc.
9. Galderma S.A.
10.Eli Lilly and Company
11.Mylan N.V.
12.GlaxoSmithKline plc
13.Sanofi,
14.LEO Pharma A/S.

► Get Market Research Latest Trends :

♦ Bulimia Nervosa Market https://www.maximizemarketresearch.com/market-report/bulimia-nervosa-market/188570/

♦ Bone Screw System Market https://www.maximizemarketresearch.com/market-report/bone-screw-system-market/121454/

♦ Mother Child Healthcare Market https://www.maximizemarketresearch.com/market-report/mother-child-healthcare-market/187324/

♦ Global Bioengineered Protein Drugs Market https://www.maximizemarketresearch.com/market-report/global-bioengineered-protein-drugs-market/39151/

♦ Pregabalin Market https://www.maximizemarketresearch.com/market-report/global-pregabalin-market/109027/

♦ Global Adhesion Barrier Device Market https://www.maximizemarketresearch.com/market-report/global-adhesion-barrier-device-market/10968/

♦ Global Alzheimer's Disease Diagnostic Market https://www.maximizemarketresearch.com/market-report/global-alzheimers-disease-diagnostic-market/116921/

♦ Global Hospital Information Systems Market https://www.maximizemarketresearch.com/market-report/global-hospital-information-systems-market/83327/

♦ Global Eye Tracking System Market https://www.maximizemarketresearch.com/market-report/global-eye-tracking-system-market/23340/

♦ Epilepsy Treatment Market https://www.maximizemarketresearch.com/market-report/epilepsy-treatment-market/124423/

♦ Global Pulmonary Arterial Hypertension Market https://www.maximizemarketresearch.com/market-report/pulmonary-arterial-hypertension-market/122335/

♦ Global Pharmaceutical Continuous Manufacturing Market https://www.maximizemarketresearch.com/market-report/global-pharmaceutical-continuous-manufacturing-market/37204/

♦ Heparin Market https://www.maximizemarketresearch.com/market-report/global-heparin-market/103436/

♦ Global Nuclear Medicine/Radiopharmaceuticals Market https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-radiopharmaceuticals-market/7741/

♦ Global Anti Malarial Drugs Market https://www.maximizemarketresearch.com/market-report/global-anti-malarial-drugs-market/24938/

► Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

► About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatology Drugs Market Expansion with Biologics and Advanced Topical Therapies here

News-ID: 3958274 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a Robust 13.71% CAGR
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a …
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million. Bangladesh Ceramics Tiles Market Overview: The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030. Furfural Market Overview: The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to Grow at a 5.59% CAGR Through 2032
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to …
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion. Chemical Protective Clothing Market Overview: The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range of
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR Growth to 2032
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR …
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion. Prefabricated Homes Market Overview: The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizes

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the